Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma (NCT03749018) | David Bond, MD | 2019-01-02 |
Track Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.